Tectonic Therapeutic, Inc. Common Stock TECX
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-07T02:09:30.524Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T22:53:20.042970641Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-07T02:09:28.243356+00:00
Tectonic Therapeutic, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 15.83 | 353.8% | 40.1% | |||
| 25Δ | 17.90 | 282.5% | 30.9% | |||
| 30Δ | 19.47 | 233.7% | 24.0% | |||
| 35Δ | 20.69 | 206.9% | 19.4% | |||
| 40Δ | 23.47 | 110.2% | 12.1% | 21.74 | 191.4% | 16.1% |
| 45Δ | 23.14 | 122.0% | 12.0% | 22.83 | 182.2% | 13.2% |
| 50Δ | 22.82 | 133.7% | 11.8% | 24.05 | 189.6% | 11.8% |
| 55Δ | 22.49 | 144.6% | 11.6% | 25.58 | 202.7% | 10.6% |
| 60Δ | 22.12 | 130.4% | 10.0% | 28.28 | 235.9% | 10.0% |
| 65Δ | 21.74 | 116.2% | 8.4% | 32.22 | 279.7% | 9.5% |
| 70Δ | 21.37 | 102.1% | 6.7% | 38.54 | 329.1% | 8.7% |
| 75Δ | 21.00 | 87.9% | 5.1% | |||
| 80Δ | 20.62 | 73.7% | 3.4% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 15.83
- IV
- 353.8%
- B/E move
- 40.1%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 17.90
- IV
- 282.5%
- B/E move
- 30.9%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 19.47
- IV
- 233.7%
- B/E move
- 24.0%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 20.69
- IV
- 206.9%
- B/E move
- 19.4%
40Δ
- Pseudo strike
- 23.47
- IV
- 110.2%
- B/E move
- 12.1%
- Pseudo strike
- 21.74
- IV
- 191.4%
- B/E move
- 16.1%
45Δ
- Pseudo strike
- 23.14
- IV
- 122.0%
- B/E move
- 12.0%
- Pseudo strike
- 22.83
- IV
- 182.2%
- B/E move
- 13.2%
50Δ
- Pseudo strike
- 22.82
- IV
- 133.7%
- B/E move
- 11.8%
- Pseudo strike
- 24.05
- IV
- 189.6%
- B/E move
- 11.8%
55Δ
- Pseudo strike
- 22.49
- IV
- 144.6%
- B/E move
- 11.6%
- Pseudo strike
- 25.58
- IV
- 202.7%
- B/E move
- 10.6%
60Δ
- Pseudo strike
- 22.12
- IV
- 130.4%
- B/E move
- 10.0%
- Pseudo strike
- 28.28
- IV
- 235.9%
- B/E move
- 10.0%
65Δ
- Pseudo strike
- 21.74
- IV
- 116.2%
- B/E move
- 8.4%
- Pseudo strike
- 32.22
- IV
- 279.7%
- B/E move
- 9.5%
70Δ
- Pseudo strike
- 21.37
- IV
- 102.1%
- B/E move
- 6.7%
- Pseudo strike
- 38.54
- IV
- 329.1%
- B/E move
- 8.7%
75Δ
- Pseudo strike
- 21.00
- IV
- 87.9%
- B/E move
- 5.1%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 20.62
- IV
- 73.7%
- B/E move
- 3.4%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 132.52% | |
| 134.73% | |
| 131.16% | |
| 133.39% | |
| 140.27% | |
| 139.85% | |
| 148.12% | |
| 144.71% | |
| 139.68% | |
| 137.16% |
Biotechnology
TENX
Description unavailable
More →TGTX
TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and…
More →TNGX
Tango Therapeutics Inc. is a leading clinical-stage biotechnology firm at the forefront of cancer treatment innovation, specializing in synthetic lethality and targeted therapies.…
More →TNXP
Description unavailable
More →TNYA
Description unavailable
More →TRAX
Description unavailable
More →